Previous 10 | Next 10 |
2023-08-22 14:11:51 ET More on Ocugen Ocugen ( OCGN ) Q2 2023 Earnings Call Transcript Former US Sen. Pat Toomey joins Ocugen's new business advisory board Seeking Alpha’s Quant Rating on Ocugen Earnings data for Ocugen For further details ...
2023-08-22 12:00:21 ET Image source: The Motley Fool. Ocugen (NASDAQ: OCGN) Q2 2023 Earnings Call Aug 22, 2023 , 8:30 a.m. ET Operator Continue reading For further details see: Ocugen (OCGN) Q2 2023 Earnings Call Transcript
2023-08-21 16:35:40 ET More on Ocugen Ocugen Q2 2023 Earnings Preview Former US Sen. Pat Toomey joins Ocugen's new business advisory board Hot Stocks: ANF, URBN and PANW rise on earnings; A, XPEV fall on weak outlooks; OCGN slides Ocugen's gene therapy for vi...
Conference Call and Webcast Tomorrow at 8:30 a.m. ET • Investigational New Drug (IND) Applications Cleared for Novel Gene Therapies for Geographic Atrophy Secondary to AMD and for Stargardt Disease • OCU400 Clinical Study Results Update Expected This Quarter ...
2023-08-21 12:55:21 ET More on Ocugen Former US Sen. Pat Toomey joins Ocugen's new business advisory board Hot Stocks: ANF, URBN and PANW rise on earnings; A, XPEV fall on weak outlooks; OCGN slides Ocugen's gene therapy for vision disorder gets FDA orphan drug tag ...
2023-08-20 17:35:44 ET Major earnings expected after the bell on Monday include: Zoom Video Communications ( ZM ) Ocugen ( OCGN ) Coles group Limited ( CM ) Agora ( API ) Qifu Technology ( QFIN ) For further details see: Notable earnings a...
MALVERN, Pa., Aug. 18, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that it will host a conference call and live...
2023-07-13 07:00:03 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech may be a great sector for risk-seeking investors to find opportunity. That said, for every biotech stock worth buying, there are plenty that fit into the “ biotech stocks to ...
MALVERN, Pa., June 30, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that the Company’s Chairman, CEO and ...
MALVERN, Pa., June 09, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that the Company’s 2023 Annual Meetin...
News, Short Squeeze, Breakout and More Instantly...
• Initiated Phase 2 clinical trial MALVERN, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and va...
2024-07-11 08:45:00 ET It hasn't been a stellar year so far for biotech companies. The industry, as measured by the SPDR S&P Biotech ETF , is up just 4% since January, significantly lagging the S&P 500 's nearly 17% gain. Of course, it's not hard to find stocks that have...